Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: Thailand Medical News  Jan 27, 2020  4 years, 2 months, 4 weeks, 16 hours, 46 minutes ago

New Neurons Discovered Could Pave The Way For Better Diet Drugs To Curb Obesity

New Neurons Discovered Could Pave The Way For Better Diet Drugs To Curb Obesity
Source: Thailand Medical News  Jan 27, 2020  4 years, 2 months, 4 weeks, 16 hours, 46 minutes ago
Have you ever eaten something, gotten sick and then didn’t want to eat that food again because of how it made you feel? That’s because a signal from the gut to the brain produced that sickness, creating a taste aversion.
 
Typically, conventional wisdom renders there’s one circuit in the brain that suppresses eating and it comes from the stomach and makes you feel sick if you activate it too hard. Eating a portioned meal makes your body happy, though, even while stimulating a signal to the brain to stop eating, according to Michigan Diabetes Research Center’s director, Dr Martin Myers Jr., M.D. Ph.D.
 
Dr Myers Told Thailand Medical News, “Therefore, there must be a circuit that stops normal feeding without the adverse effects, right?”
 
A new study may have discovered this second circuit in mice. Dr Myers along with Dr Randy Seeley, Ph.D, the director of the Michigan Nutrition Obesity Research Center, and a team of medical researchers sought to better understand which part of the brain curbs appetite and which neurons play a role in making mice want to eat or not eat.


 
The findings of the study was published in the journal Cell Metabolism
 
It was observed that the gut-brain signal that suppresses appetite is triggered by a type of neuron, containing calcitonin receptor (CALCR), which lives in a structure of the hindbrain called the medulla. Interestingly enough, these neurons didn’t need to be active in the brain for gut sickness to cause an aversive response.
 
Dr Myers, whose group found they could genetically activate those CALCR neurons to do just that added, “This suggested we might be able to dissociate the brainstem systems that stop feeding from those that cause nausea.”
 
As there are neurons that can suppress eating but also cause aversive effects, that must mean there are different types of neurons, or circuits, in the brain that can terminate feeding with differing emotional responses.
 
Upon inactivating the CALCR neurons, the researchers were surprised to make another discovery, which contradicted the idea that the brain only controls short term meal sizes and consumption.
 
It was discovered that turning these neurons “off” didn’t only interfere with the suppression of feeding by gut signals, but it also caused an ongoing increase in food intake. The mice became obese, suggesting that the brainstem systems don’t only control meal size, but the amount of food consumed long term. This created a predisposition to obesity because of the energy imbalance in the mice (more input than output).
 
Whereas, activating CALCR neurons decreased the mice’s food intake and body weight without any aversive gut effects. In the study, Dr Myers and his team found another neuron, CCK, also decreased food intake and body weight but created an aversive internal response, unlike the CALCR neurons. The difference between the two neurons was found in their circuits.
 
Dr Myers added, “CCK activates what we would call a ‘yucky circuit’. The neurons activate a certain cell, CGRP cells, which create that sick feeling. Unlike CCK, activated CALCR neurons follow a ‘yummy circuit,’ activating non-CGRP cells.”
 
Currently, obesity affects more than one-third of the adult population in developed countries, which can lead to diabetes or other serious, long-term health conditions like heart disease, explains Dr Myers, who is also the director of MDiabetes.
 
Though many diet drugs work, they often make people feel nauseous after they take them. Obesity remains a condition difficult to pharmaceutically manage, since the treatment options have limited therapeutic utility. A drug that turns “on” CALCR and turns off “CGRP” could greatly benefit patients with obesity by suppressing feeding and creating a long term control of food intake and body weight.
 
Dr Myers further added, “If we could figure out a drug for individuals with obesity that suppresses food intake to produce long term weight loss without the negative side effects, it could absolutely change someone’s life.”
 
Reference: “Calcitonin Receptor Neurons in the Mouse Nucleus Tractus Solitarius Control Energy Balance via the Non-aversive Suppression of Feeding” by Wenwen Cheng, Ian Gonzalez, Warren Pan, Anthony H. Tsang, Jessica Adams, Ermelinda Ndoka, Desiree Gordian, Basma Khoury, Karen Roelofs, Simon S. Evers, Andrew MacKinnon, Shuangcheng Wu, Henriette Frikke-Schmidt, Jonathan N. Flak, James L. Trevaskis, Christopher J. Rhodes, So-ichiro Fukada, Randy J. Seeley, Darleen A. Sandoval, David P.Olson, Clemence Blouet and Martin G. Myers Jr., 16 January 2020, Cell Metabolism.
DOI: 10.1016/j.cmet.2019.12.012

 

MOST READ

Jun 10, 2023  11 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19